Apr. 12, 2017 

Using Partnerships, Hua Medicine Brings Novel Diabetes Drug to Phase III

Dec. 23, 2016 

Hua Medicine Announces CDISC Membership – A PivotalMilestone to Establish the First CDISC Member from China Pharma

Dec. 04, 2016 

The Chinese Dream on its Fourth Anniversary

Jul. 20, 2016 

Sea turtles come back to China's biomedical industry


Apr. 25, 2016 

Hua Medicine closes $50M round, looks to new diabetes target

Apr. 25, 2016 

Hua Medicine Lands $50 Million in a Series C Funding

Feb. 12, 2015 

For many of China's biotech brains-in-exile, it's time to come home

Oct. 23, 2014 


Mar. 26, 2014 

Hua Medicine tests glucokinase activator in Chinese diabetics

Mar. 20, 2014 

Hua Medicine Reports Strong Results for Early Diabetes Drug Trial

Nov. 29, 2012 

China’s Green Channel Significantly Shortened Filing Time For Start-up Hua Medicine

Nov. 23, 2012 

Hua Medicine Advances Diabetes Treatment toward Trial

Dec. 20, 2011 

China's Hua Medicine Licenses Worldwide Rights To Roche Diabetes Compound, More Deals On The Way

Nov. 23, 2011 

After Launching Corporate Venture Fund, WuXi Shifts Attention To China's Domestic Market: China Earnings Roundup

Oct. 13, 2011 

With $50M in Hand, Hua Aims To License Drugs for China

Sep. 20, 2011 

Hua Medicine Raises $50 Million to Develop and Commercialize Drugs

Sep. 19, 2011 

Hua Medicine: A China Startup Led by Industry Veterans

Sep. 19, 2011 

Meet China's New Innovators:Hua Medicine Looks To Take Flight With U.S. Venture Backing

Jun. 30, 2011 

Biotech Innovation in China:'We Can Do it From A to Z'